Investor Relations

REVA Medical, Inc. ("REVA" or the "Company") completed its initial public offering of CDIs (CHESS Depository Interests) on December 17, 2010 and began trading on the Australian Securities Exchange ("ASX") on December 23, 2010, under the symbol "RVA." Ownership interests in REVA may be held in either CDIs or shares of common stock, but only CDIs may be traded on the ASX. Ten CDIs are equal to one share of common stock. ...more »

View all »   RSSRecent Releases

May 21, 2015
REVA Releases Initial Clinical Results for Fantom Scaffold

May 21, 2015
Initial Clinical Results for Fantom Scaffold

View all »Events & Presentations

May 21, 2015 at 2:50 PM CET
Presentation at EuroPCR 2015

May 27, 2015 at 5:30 PM PT
Annual General Meeting of Stockholders